APA (7th ed.) Citation

Visram, A., Torre, A. D. L., White, D., Su, J., Masih-Khan, E., Chu, M., . . . Reece, D. Real world data on outcomes of anti-CD38 antibody treated, including triple class refractory, patients with multiple myeloma: A multi-institutional report from the Canadian Myeloma Research Group (CMRG) Database. Nature Publishing Group.

Chicago Style (17th ed.) Citation

Visram, A., et al. Real World Data on Outcomes of Anti-CD38 Antibody Treated, Including Triple Class Refractory, Patients with Multiple Myeloma: A Multi-institutional Report from the Canadian Myeloma Research Group (CMRG) Database. Nature Publishing Group.

MLA (9th ed.) Citation

Visram, A., et al. Real World Data on Outcomes of Anti-CD38 Antibody Treated, Including Triple Class Refractory, Patients with Multiple Myeloma: A Multi-institutional Report from the Canadian Myeloma Research Group (CMRG) Database. Nature Publishing Group.